(Tromsø 22. October 2018) Rolf E. Engstad, CSO of Biotec BetaGlucans
has purchased 20 000 shares in Biotec Pharmacon at NOK 4.42 per share. After
this transaction holds Engstad 450.774 shares and 40.000 options in Biotec
Pharmacon
For further information, please contact

Børge Sørvoll
CFO
+47 952 90 187
borge.sorvoll@biotec.no

